Form Type: 4

SEC EDGAR Link
Accession Number:0000874015-17-000063
Date:2017-10-18
Issuer: IONIS PHARMACEUTICALS INC (IONS)
Original Submission Date:

Reporting Person:

PARSHALL B LYNNE
C/O IONIS PHARMACEUTICALS, INC.
2855 GAZELLE COURT CARLSBAD, CA 92010

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2017-10-18 M 7,785 a $14.69 33,526 direct
COMMON STOCK 2017-10-18 S 7,785 d $65.00 25,741 direct
COMMON STOCK 2017-10-18 M 8,333 a $39.87 34,074 direct
COMMON STOCK 2017-10-18 S 8,333 d $65.00 25,741 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
EMPLOYEE STOCK OPTION (RIGHT TO BUY) 14.69 2017-10-18 deemed execution date M 7,785 (d) 2017-01-02 2020-01-29 common stock 7,785 $14.69 0 direct
EMPLOYEE STOCK OPTION (RIGHT TO BUY) 39.87 2017-10-18 deemed execution date M 8,333 (d) 2015-01-02 2021-01-01 common stock 8,333 $39.87 74,167 direct
Footnotes
IDfootnote
f1 acquired as a result of exercising a stock option pursuant to rule 10b5-1 trading plan. the purchase and sale reported on this form 4 was effective pursuant to rule 10b5-1 trading plan adopted by the reporting person on 8/8/2017.
f2 grant of 1/2/2014 to reporting person of stock options under the ionis pharmaceuticals, inc. 2011 equity incentive plan. 25% of the shares subject to the option vest and become exercisable on 1/2/2015. thereafter, the remaining shares subject to the option vest and become exercisable in 36 equal monthly installments, at the rate of 20,625 shares per year. following this transaction, the option was exercisable as to 69,010 on 10/18/2017.
WhaleWisdom Logo

Elevate your investments